Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 02, 2026
Why Is Leslie's (LESL) Stock Down -13.99% Today?

Why Is Leslie's (LESL) Stock Down -13.99% Today?

Key Takeaways

  • Move: Leslie's shares were down roughly 14%, trading near $0.1445 in early trading versus a prior-session close of $0.168.
  • Primary catalyst: The decline extends the selloff that followed the company's September 30 filing for prearranged Chapter 11 bankruptcy protection.
  • Secondary driver: Existing common shareholders face the prospect of heavy dilution or near-total loss of value as lenders are expected to take majority ownership on emergence.
  • Broader context: The stock has collapsed more than 97% over the past year, and the company now faces potential delisting from Nasdaq.
  • What to watch: Court approval of debtor-in-possession (DIP) financing, further store-closure announcements, and any details on the treatment of existing equity.

Opening Summary

Leslie's, Inc. (LESL), the largest direct-to-customer brand in the U.S. pool and spa care industry, extended its steep decline on Thursday, with shares trading down about 14% to near $0.1445 in early trading after closing the prior session at $0.168. The drop is the latest leg of a broader collapse triggered by the company's decision to file for prearranged Chapter 11 bankruptcy protection, a move that markets are interpreting as likely to leave existing equity holders with little or no recovery.

Chapter 11 Filing Drives Continued Selloff

The dominant force behind the move is Leslie's voluntary Chapter 11 filing in the U.S. Bankruptcy Court for the Southern District of Texas. Under a Restructuring Support Agreement backed by more than 80% of its existing lenders, the company plans to eliminate approximately $685 million—roughly 90%—of its funded debt, secure $90 million in new-money debtor-in-possession financing, and obtain $60 million in fully backstopped equity financing. The company also seeks approval for a $225 million DIP asset-based financing facility from its existing ABL lenders.

While the restructuring is designed to strengthen the balance sheet and keep the business operating, it carries severe implications for common shareholders. Upon emergence, which the company targets for early 2027, a group of existing lenders is expected to hold majority ownership. That ownership shift is widely seen as substantially diluting, or effectively wiping out, the value of existing shares—an outcome that has kept intense selling pressure on the stock in the days since the filing.

Store Closures and Equity Dilution Weigh on Sentiment

As part of the restructuring, Leslie's also announced the closure of 76 stores, adding an operational component to the financial reorganization. The company said it will continue to evaluate its real estate portfolio to align its footprint with long-term demand, signaling that additional closures remain possible. Although management stressed that the chain is "here to stay" and that remaining locations and digital platforms will continue operating without interruption, the combination of a shrinking store network and the pending transfer of ownership has deepened investor concerns about the path forward for equity holders.

Delisting and Financial Distress in Focus

Compounding the pressure, the company's securities filings reference a notice of delisting or failure to satisfy continued listing standards, a reminder that the stock's prolonged slide has put its Nasdaq listing at risk. The shares, which traded as high as $12.53 over the past year, have fallen to around $0.14, and the company had previously warned of substantial doubt about its ability to continue as a going concern. Weak peak-season results—third-quarter revenue declined 8.4% to $458.5 million—and the withdrawal of full-year guidance earlier this year underscored the operational challenges that preceded the filing.

Market Context and Trading Activity

Trading activity has been extraordinarily heavy relative to the stock's recent norm. Sessions immediately following the bankruptcy announcement saw volumes in the millions of shares, far above the several-hundred-thousand-share levels typical in prior weeks, reflecting active liquidation by investors exiting positions. The move is idiosyncratic rather than a reflection of broader market weakness: the collapse is tied directly to company-specific restructuring news rather than a sector or macroeconomic catalyst. Technically, the stock is trading near its 52-week low, well below prior support levels, with no meaningful recovery in sight as bankruptcy proceedings get underway.

What Comes Next for LESL

Looking ahead, investors will focus on the bankruptcy court's handling of the company's first-day motions, including approval of the DIP financing facilities intended to fund operations through the process. Additional store-closure announcements and further details on the treatment of existing common stock will be critical, since the restructuring agreement does not specify the ultimate recovery available to current shareholders. Risks remain elevated: the proceedings could result in full or near-full impairment of equity value, and the company must still demonstrate it can stabilize operations and cash flow while navigating delisting pressures. The path to emergence in early 2027 remains subject to court approval and execution risk.

Trending AI Robots

For traders seeking data-driven signals across thousands of stocks, Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots. Tickeron offers hundreds of bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, helping users explore automated approaches tailored to different market environments. Explore the Trending AI Robots page to see which strategies are currently leading.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LESL

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


LESL's RSI Indicator is remaining in oversold zone for 7 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where LESL advanced for three days, in 177 of 238 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

LESL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LESL as a result. In 85 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 89%.

The 50-day moving average for LESL moved below the 200-day moving average on September 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LESL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for LESL entered a downward trend on September 18, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LESL's P/B Ratio (-17.823) is slightly lower than the industry average of (1.755). P/E Ratio (175.500) is within average values for comparable stocks, (241.673). Projected Growth (PEG Ratio) (0.070) is also within normal values, averaging (1.113). Dividend Yield (0.000) settles around the average of (0.017) among similar stocks. P/S Ratio (0.004) is also within normal values, averaging (1.033).

The Tickeron Price Growth Rating for this company is 99 (best 1 - 100 worst), indicating slightly worse than average price growth. LESL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LESL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

Notable companies

The most notable companies in this group are Ulta Beauty (NASDAQ:ULTA), Best Buy Company (NYSE:BBY), Tractor Supply Co (NASDAQ:TSCO), Five Below (NASDAQ:FIVE), GameStop Corp (NYSE:GME), Bath & Body Works (NYSE:BBWI), RH (NYSE:RH), 1-800-FLOWERS.COM (NASDAQ:FLWS).

Industry description

The specialty stores sector includes companies dedicated to the sale of retail products focused on a single product category, such as clothing, carpet, books, or office supplies. A specialty store could face intense competition from big-box departmental chains, and therefore offering an adequate collection of the product type it specializes in is key in maintaining/growing its market.

Market Cap

The average market capitalization across the Specialty Stores Industry is 4.13B. The market cap for tickers in the group ranges from 3.1K to 50.98B. ANCTF holds the highest valuation in this group at 50.98B. The lowest valued company is SIMPQ at 3.1K.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Stores Industry was -1%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 4%. ABLV experienced the highest price growth at 53%, while LESL experienced the biggest fall at -57%.

Volume

The average weekly volume growth across all stocks in the Specialty Stores Industry was 38%. For the same stocks of the Industry, the average monthly volume growth was 18% and the average quarterly volume growth was -0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 61
Price Growth Rating: 61
SMR Rating: 63
Profit Risk Rating: 90
Seasonality Score: 33 (-100 ... +100)
View a ticker or compare two or three
LESL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry SpecialtyStores

Industry
N/A
Address
2005 East Indian School Road
Phone
+1 602 366-3999
Employees
3790
Web
https://www.lesliespool.com
Interact to see
Advertisement
I've been following ANTX, a biopharmaceutical company based in Menlo Park, California, that develops novel small molecule therapeutics from its proprietary boron chemistry platform. The focus is on underserved areas like infectious diseases, with the lead candidate epetraborole advancing in Phase 3 trials for non-tuberculous mycobacterial (NTM) lung disease and acute melioidosis. The pipeline also includes AN2-502998 for chronic Chagas disease in preclinical stages, along with programs in oncology.
Tilly's, Inc. (TLYS) operates as a specialty retailer specializing in casual apparel, footwear, accessories, and hardgoods aimed at young men, women, boys, and girls. The company focuses on branded fashion inspired by action sports, surf, and skate culture, offering products like tops, bottoms, swimwear, backpacks, hats, and sunglasses from well-known brands such as Vans and Hurley. With approximately 223 stores in malls and lifestyle centers, complemented by e-commerce through www.tillys.com, Tilly's effectively combines physical and digital sales channels.
Aemetis, Inc. (AMTX) is a renewable natural gas and renewable fuels company focused on developing and commercializing low- and negative-carbon intensity products that replace petroleum-based fuels. The company operates through segments including California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. Its core business model centers on converting agricultural waste—such as dairy manure into biogas and corn/wood waste into ethanol—into high-value biofuels like renewable natural gas (RNG), ethanol, biodiesel, and sustainable aviation fuel precursors.
Silvaco Group, Inc. (SVCO) provides technology computer-aided design (TCAD) software, electronic design automation (EDA) software, and semiconductor intellectual property (SIP) solutions. The company helps semiconductor and photonics firms design, simulate, and optimize processes from atomic-level modeling to complex system-on-chip (SoC) development. Its business centers on licensing software tools and IP blocks, along with engineering services, targeting high-growth areas like AI, power devices, automotive, foundries, and 5G/6G mobile.
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ORIC Pharmaceuticals shares are down approximately 21% in premarket trading on April 1, 2026, from a prior session close of approximately $12.19, placing the premarket price near $9.63. The primary catalyst is the after-market release of Phase 1b dose optimization data for rinzimetostat (ORIC-944) on March 31, alongside the selection of 400 mg once daily as the recommended Phase 3 dose for the Himalayas-1 registrational trial.
Shares of Target Hospitality Corp. (Nasdaq: TH) surged approximately 38% during Wednesday's trading session, climbing from a prior close of $9.28 to approximately $12.81. The primary catalyst is the company's announcement of a landmark multi-year lease and services agreement worth over $550 million with a top-five global hyperscaler to build and operate a data center workforce community in North Texas.
Shares of Turning Point Brands (TPB) are falling sharply intraday on April 1, 2026, shedding approximately 15% from their prior session close of roughly $87.41, placing the stock near $74.30. The primary catalyst is broad investor risk-off selling tied to mounting trade-policy uncertainty ahead of President Trump's sweeping tariff announcements scheduled for April 2 — a day the administration has branded "Liberation Day".
Shares of Philip Morris International fell approximately 8% during intraday trading on April 1, 2026, dropping from a prior close of $165.34 to around $152.11. A sharp, broad-based market selloff — amplified by renewed trade policy tensions — is acting as the primary macro catalyst behind the decline.
WDC shares surged approximately +10% in Wednesday's session, advancing to approximately $296–$297 from a prior close near $269.82 on March 31, 2026. The primary catalyst is a major analyst upgrade: Bernstein raised its rating on Western Digital from Market Perform to Outperform and dramatically doubled its price target to $340 from $170.
I've been following CG Oncology, Inc. (CGON), a late-stage clinical biopharmaceutical company dedicated to developing and commercializing cretostimogene grenadenorepvec. This investigational oncolytic immunotherapy aims to serve as a bladder-sparing therapeutic for patients with non-muscle invasive bladder cancer (NMIBC). The company's focus remains on pushing this intravesical therapy through Phase 3 trials to address high unmet needs in BCG-unresponsive and intermediate-risk NMIBC, where treatments like BCG frequently fall short. In the broader biotech landscape, CG Oncology stands out with cretostimogene's encouraging durability and tolerability, which could position it as a foundational therapy. From what I see, these solid fundamentals—bolstered by strong clinical data and regulatory steps—have directly supported the recent stock price gains amid positive trial developments.
From what I see, Home Depot (HD) remains the world's largest home improvement retailer, operating over 2,300 stores across North America with a broad selection of products for construction, renovation, and maintenance. The company blends big-box retail with an expanding e-commerce platform and tailored services for professional contractors, drawing revenue from both do-it-yourself (DIY) consumers and do-it-for-me (DIFM) pros. In a competitive landscape against players like Lowe's, HD maintains dominance through its scale, efficient supply chain, and strong loyalty programs. Much of its performance ties directly to the housing market—home sales, remodeling, and repairs—which explains the recent pressure on the stock from subdued activity and high mortgage rates limiting turnover and major projects.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.